Sexual Health & Reproductive.
Targeted peptide therapy for sexual health, arousal pathways, and HPG-axis support.
Sexual Health & Reproductive.
Targeted peptide therapy for sexual health, arousal pathways, and HPG-axis support.
This category addresses sexual function, libido, and reproductive endocrinology with therapies that target central arousal pathways and the hypothalamic-pituitary-gonadal (HPG) axis. PT-141 is FDA-approved; Gonadorelin is widely used in TRT fertility-preservation protocols.
What your provider evaluates
Provider review considers the full clinical picture before any recommendation is made.
Medical history
Conditions, prior diagnoses, allergies, and relevant contraindications.
Current medications
Potential interactions, duplicate therapies, and safety concerns.
Treatment goals
Symptoms, priorities, tolerance, and practical preferences.
Labs where indicated
Baseline and follow-up labs are considered when they change clinical decisions.
Care starts with
provider review.
Lumora is not a checkout flow. A licensed provider reviews fit and safety before treatment.
- 01
Free assessment
Share goals, history, and relevant symptoms. No card required.
- 02
Provider review
A licensed provider evaluates eligibility, safety factors, and fit.
- 03
Recommendation
If appropriate, the provider shares a plan and pricing before you commit.
- 04
Ongoing care
Treatment can be adjusted, paused, or stopped based on response and safety.
Start with
an assessment.
Explore whether sexual health & reproductive care is a fit. A provider reviews your assessment before treatment is recommended.